Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | N/A | 103 | 24 | N/A | N/A |
| Accounts receivable | -5 | -103 | 178 | -386 | -11 |
| Other Working Capital | -75 | -56 | -429 | 203 | -18 |
| Other Operating Activity | -1,338 | -3,398 | -3,595 | -3,926 | -1,281 |
| Operating Cash Flow | $-1,417 | $-3,453 | $-3,822 | $-4,108 | $-1,310 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -208 | -422 | -3,511 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -508 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 29,506 |
| Other Investing Activity | -2,755 | -10,387 | -6,760 | -589 | 141 |
| Investing Cash Flow | $-2,760 | $-10,594 | $-7,182 | $-4,100 | $29,140 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 10,212 | 8,529 | 8,405 | 575 |
| Dividend Paid | N/A | 0 | N/A | N/A | -40,741 |
| Other Financing Activity | 371 | 222 | 162 | 826 | 0 |
| Financing Cash Flow | $371 | $10,433 | $8,692 | $9,231 | $-40,165 |
| Exchange Rate Effect | -248 | -270 | 485 | 562 | N/A |
| Beginning Cash Position | 10,519 | 15,709 | 16,166 | 15,450 | 28,407 |
| End Cash Position | 6,465 | 11,824 | 14,339 | 17,035 | 16,072 |
| Net Cash Flow | $-3,807 | $-3,614 | $-2,312 | $1,023 | $-12,335 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,417 | -3,453 | -3,822 | -4,108 | -1,310 |
| Capital Expenditure | -2,760 | -10,647 | -7,182 | -3,511 | N/A |
| Free Cash Flow | -4,177 | -14,100 | -11,004 | -7,619 | -1,310 |